sST2 and Cardiac Surgery

NCT03887767 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 158

Last updated 2020-03-10

No results posted yet for this study

Summary

Evaluation of the prognosis value of sST2 dosed before cardiac surgery on prognosis of long terme prognosis after cardiac surgery.

The patients where initialy recruted for another cohort named micro-SIRS and inflammation but the gaved their consent to analyse the blood samples for other studies

Conditions

  • Cardiac Surgery

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Kada KLOUCHE, MD PhD · Hopital de Montpellier

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-25
Primary Completion
2019-12-01
Completion
2019-12-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03887767 on ClinicalTrials.gov